JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Ashwani Kumar Puri as Independent Director of the company w.e.f. May 14, 2025.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals has appointed Mr. Ashwani Kumar Puri as a Non-Executive Independent Director for a term of 5 years, effective May 14, 2025. Mr. Puri is a Chartered Accountant and Certified Management Accountant who spent over 33 years at PwC, including 22 years as a partner, and led the firm's India Advisory Services. He currently serves as an independent director on the boards of Titan Company, Travel Food Services, and Healthium Medtech. He is not related to any existing director on the JB Chemicals board and is not debarred by SEBI or any other authority from holding directorship.
This is a routine board strengthening move that adds a senior finance and governance professional to the board. No material impact on the stock is expected, though it may be viewed positively by investors focused on corporate governance quality.